Physician
Hematology
Dr. Lin H. Soe, MD
|
|
Give Review
Doctor Lin H. Soe, MD is an expert in the field of Hematology. Dr. Lin H. Soe is also published. He has 26 publications published. The lastest publication: "Intratumoral toremifene therapy and tissue distribution in the baboon.' He accepts Medicare.
Publications
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung Cancer (START): a randomized, double-blind, phase III trial.
- Ospemifene, vulvovaginal atrophy, and breast Cancer.
- Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and Breast.
- Intratumoral toremifene therapy and tissue distribution in the baboon.
- Tissue distribution of transdermal toremifene.
- Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells.
- Molecular cloning and characterization of endogenous feline Leukemia virus sequences from a cat genomic library.
- Structure of the polymorphic feline c-myc oncogene locus.
- Genetic Analysis of the feline RD-114 retrovirus-related endogenous elements.
- Nucleotide sequence of the 1.2-kb 3''-region and genotype distribution of two common c-myc alleles of the domestic cat.
- Coronavirus: a jumping RNA transcription.
- Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity.
- Multiple recombination sites at the 5'-end of murine coronavirus RNA.
- The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription.
- Primary structure and translation of a defective interfering RNA of murine coronavirus.
- Specific interaction between coronavirus leader RNA and nucleocapsid protein.
- Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs.
- RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2.
- RNA recombination of coronavirus.
- Murine coronavirus 5'-end genomic RNA sequence reveals mechanism of leader-primed transcription.
- Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase.
- Clinical studies on treatment of cerebral malaria with artemether and mefloquine.
- Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein.
- Sequence Analysis of nucleocapsid gene and leader RNA of human coronavirus OC43.
- Molecular analysis of several classes of endogenous feline Leukemia virus elements.
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of California Davis -
NewYork-Presbyterian/Queens -
University Institute of Medicine 1
Drug Facts
| NPI NUMBER | 1467524900 | |
| NPPES Provider LastName | SOE | |
| NPPES Provider FirstName | LIN | |
| NPPES Provider ZIPCode | 956828236 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 511.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 2.74 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467524900 |
| Last Name Of The Provider | SOE |
| First Name Of The Provider | LIN |
| View All |
Similar Doctors
|
|
Dr. Ernest N. Lo, MD |